Trial intelligence / Profile preview

Clofibrate dose comparison in term neonatal jaundice

IRCT20180610040036N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of clofibride in jaundice (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Total serum bilirubin. Started Jul 2017; status: completed.

02

Drugs

clofibride
03

Conditions

jaundice

Beyond the preview

Go deeper on IRCT20180610040036N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180610040036N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call